Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
Condition(s):Haematologic Disease; Haematological MalignancyLast Updated:September 15, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Haematologic Disease; Haematological MalignancyLast Updated:September 15, 2023Recruiting
Condition(s):Hematologic DisordersLast Updated:February 6, 2024Recruiting
Condition(s):Angiodysplasia; Hematological DiseaseLast Updated:December 21, 2023Not yet recruiting
Condition(s):Multiple Myeloma; Myeloma, Multiple; Myelomas, Multiple; Acute Myeloid Leukemia; Leukemias, Acute Myeloid; Myeloid Leukemias, Acute; Hemophilia; Hemophilia A; Hemophilia As; Hemophilia B; Hemophilia Bs; Myelodysplastic Syndrome; MDS; Lymphoma; Leukemia; Aplastic Anemia; Bleeding Disorder; Bone Marrow Transplantation; Blood Disease InfectionLast Updated:April 25, 2023Recruiting
Condition(s):Malignant Hematologic DisorderLast Updated:February 22, 2019Unknown status
Condition(s):Hematologic Diseases; NeoplasmsLast Updated:April 25, 2023Recruiting
Condition(s):Hematopoietic Stem Cell Transplantation; Malignant Hematological DiseasesLast Updated:July 6, 2023Recruiting
Condition(s):Hematologic Disorder; Bleeding Disorder; Connective Tissue Disorder; Hemophilia; Thrombosis; Von Willebrand Diseases; Thrombophilia; Rare Bleeding Disorder; Platelet Disorder; Factor IX Deficiency; Factor VIII Deficiency; Thalassemia; Sickle Cell DiseaseLast Updated:March 20, 2024Recruiting
Condition(s):Hematological Diseases; Carbapenem-resistant Enterobacteriaceae; Carbapenem-resistant Pseudomonas Aeruginosa; Carbapenem-resistant Acinetobacter BaumanniiLast Updated:August 12, 2021Unknown status
Condition(s):Non-Malignant Hematologic DisordersLast Updated:March 24, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.